HPV vaccine protection lasts more than 6 years

The human papillomavirus (HPV) vaccine Cervarix, produced by GlaxoSmithKline, offers protection against the two major cancer-causing strains of HPV, (HPV-16 and HPV-18) for more than 6 years, according to research published online today in the British medical journal the Lancet. The analysis, led by Dr. Cosette Wheeler from the